THERAPIE DE COMBINAISON DE MOLECULES CD3 DE LIAISON A L'ANTIGENE BISPECIFIQUES D'ACTIVATION DES LYMPHOCYTES T ET D'ANTAGONISTES DE RECEPTEUR 1 DE L'ACIDE FOLIQUE ET DE LIAISON A L'AXE PD-1

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG

发明人:

KLEIN, CHRISTIAN,KARANIKAS, VAIOS,UMANA, PABLO,ZIPPELIUS, ALFRED,THOMMEN, DANIELA,SCHREINER, JENS

申请号：

CA2966566

公开号：

CA2966566A1

申请日:

2015.11.16

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The present invention generally relates to T cell activating bispecific antigen binding molecules, PD-1 axis binding antagonists, and in particular to combination therapies employing such T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists, and their use of these combination therapies for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/